Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Growth by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Organization Size (Small and Medium Organizations and Large Organizations), Offerings (Products, Platforms, and Services), Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, and Others), Clinical Indication (Cardiovascular Diseases, Neurodegenerative Diseases, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, and Others)

  • Report Date : May 2022
  • Report Code : TIPRE00029238
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 208

The Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is expected to reach US$ 1,870.3 million by 2028 from US$ 816.0 million in 2021; it is estimated to grow at a CAGR of 12.6% from 2021 to 2028.

In-silico clinical trials can supplement phase II drug trials to explore the safety and efficacy in the more infrequent phenotypes that usually appear only in phase III and predict the dose-effect relationship. Computational study in natural drug discovery is used to determine the metabolic pathways of active molecules and find the new targets and new molecules with high affinity to those targets. For instance, camptothecin derivatives (monoterpene-indole alkaloids) have been clinically employed as antitumor drugs. Such studies may explain how an in-silico metabolic analysis can improve the experimental decorations to gain more comprehensible biological information. Another aspect of human trials is that they are expensive, lengthy, and are typically designed with a narrow scope. But in-silico trials can be designed to answer a wide variety of relevant questions by providing sufficient statistical power to test the different hypotheses with a relatively small increase in resources associated with evaluating more models once the computational machinery is developed and implemented.

Furthermore, unlike conventional clinical trials, in-silico clinical trials are readily approved and authorized by the food and drug administration (FDA). Incrementally but inevitably, the in-silico clinical trial approach is expected to become the most significant evidence for regulatory evaluations. These factors indicate that the benefits mentioned above are substantially driving the in-silico trial market in Europe.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market at a promising CAGR during the forecast period.

 

Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

The market for in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into organization size, offerings, application, clinical indication, and end user. Based on organization size, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into small and medium organizations and large organizations. Based on offerings, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into products, platforms, and services. Based on application, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into product design and discovery, product development, pre-clinical targeting, assessment of drugs and other biomedical products, and others. Based on clinical indication, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into cardiovascular diseases, neurodegenerative diseases, oncology, rare diseases, metabolic diseases, immune based diseases, infectious diseases, and others. Based on end user, the in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into pharmaceutical and biopharmaceutical companies, medical technology companies, contract research organizations, and others. By country, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into Germany, the UK, France, Spain, Italy, and the rest of Europe.

InSilicoTrials Technologies; Feops; CADFEM Medical GmbH; Dassault Systèmes SE; Virtonomy GmbH; Certara Inc.; Computational Life; NOVA; TwInsight Medical; Ansys, Inc.; Synopsys, Inc.; Sensyne Health plc.; and Cerner Corporation are among the leading companies in the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market.                

Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Report Scope

Report Attribute Details
Market size in 2021 US$ 816.0 Million
Market Size by 2028 US$ 1,870.3 Million
Global CAGR (2021 - 2028) 12.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Organization Size
  • Small and Medium Organizations and Large Organizations
By Offerings
  • Products
  • Platforms
  • Services
By Application
  • Product Design and Discovery
  • Product Development
  • Pre-Clinical Targeting
  • Assessment of Drugs and Other Biomedical Products
By Clinical Indication
  • Cardiovascular Diseases
  • Neurodegenerative Diseases
  • Oncology
  • Rare Diseases
  • Metabolic Diseases
  • Immune Based Diseases
  • Infectious Diseases
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • InSilicoTrials Technologies
  • Feops
  • CADFEM Medical GmbH
  • Dassault Syst
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    1. InSilicoTrials Technologies
    2. Feops
    3. CADFEM Medical GmbH
    4. Dassault Systèmes SE
    5. Virtonomy GmbH
    6. Certara Inc.
    7. Computational Life
    8. NOVA
    9. TwInsight Medical
    10. Ansys, Inc.
    11. Synopsys, Inc.
    12. Sensyne Health plc.
    13. Cerner Corporation       
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo